4th Annual SNO/EANO Highlights of 2025 Webinar
The Society for Neuro-Oncology (SNO) and the European Association of Neuro-Oncology (EANO) are pleased to present the 4th Annual SNO/EANO Highlights Webinar, a live virtual event featuring outstanding scientific contributions from the 2025 SNO and EANO Annual Meetings.
This one-hour webinar is designed to showcase high-impact and innovative research to the international neuro-oncology community, with concise presentations followed by a moderated discussion.
Webinar Details
Date: Friday, February 6, 2026
Time: 18:30–19:30 CET
Format: Live virtual webinar (Zoom)
Registration Link: 
ZOOM Webinar
Moderators:
- Giuseppe Minniti (EANO)
- Erik Sulman (SNO)
- Anna Berghoff (EANO)
- Howard Coleman (SNO)
Program:
EANO: Martin van den Bent (Rotterdam, The Netherlands) – Final clinical and molecular analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion.
SNO: Lu Sun (Los Angeles, USA) – Dual immune checkpoint blockade for surgically accessible recurrent glioblastoma: clinical and molecular outcomes.
EANO: Irma Sakic (Zurich, Switzerland) – In vivo CRISPR screening uncovers vulnerabilities for cancer immunotherapy against glioblastoma.
SNO: Nandini Acharya (Columbus, USA) – Glioblastoma co-opts dural nociceptors to drive immune evasion and immunotherapy resistance.
EANO: Darui Jin (Heidelberg, Germany) – AI-based histopathological classification of central nervous system tumours.
SNO: Christopher H. Dampier (Bethesda, USA) – Neuropath-AI, a histopathology-based deep learning classifier for CNS tumors, achieves and improves human neuropathologist-level performance.
This Webinar is free of charge to EANO and SNO Members, to register please click here.
eEANO Youngsters Journal Club
The EANO Youngsters Journal Club, launched last year, is a webinar-based format tailored for young professionals. Staying informed and connected is vital in our dynamic field, and this innovative platform has been designed to share and discuss cutting-edge research articles spanning from basic science to clinical trials.
The Journal Club is open to all EANO members working in the diverse fields of neuro-oncology—there is no age limit, and participation is free of charge.
Programme eEANO Youngsters Journal Club:
Journal Club on "Lighting up PET imaging in IDH mutant gliomas":
- Mair, M., Werner, J.M., Weller, J. et al. Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET: A retrospective, bicentric cohort study, Neuro-Oncology, 2025;, noaf196, 10.1093/neuonc/noaf196 (23/08/2025).
Click here for the link the article.
Time and Date: November 11, 2025, from 16:30–17:30 hrs (CET)
Presenters:
- Umberto Aldo Arcidiacono (Neurosurgery Unit, ASST Fatebenefratelli Sacco, Milan, Italy)
- Tanja Buhlmann (Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital Frankfurt, Germany)
Discussants:
- Marco Riva (Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, and IRCSS Humanitas Research Hospital, Department of Neurosurgery, Rozzano, Italy)
- Sophie Veldhuijzen van Zanten (Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands)
- Maximilian J. Mair (first author) (Medical University of Vienna, Vienna, Austria)
- Gaia Ninatti (Austin Health, Melbourne, Australia)
Moderator:
- Antonio C. Fuentes-Fayos (Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba, Spain)
